Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-070839
Filing Date
2020-06-08
Accepted
2020-06-08 16:08:18
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2022064d1_4.html 4  
1 OWNERSHIP DOCUMENT tm2022064d1_4.xml 4 5288
  Complete submission text file 0001104659-20-070839.txt   6859
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RIB-X PHARMACEUTICALS, INC. 300 GEORGE STREET, SUITE 301 NEW HAVEN CT 06511
Business Address
Longcor Jarrod (Reporting) CIK: 0001545565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36598 | Film No.: 20949213